SlideShare a Scribd company logo
1 of 21
Massive transfusion in  trauma  R.Sinha, D.Roxby, R.Seshadri  Flinders Medical Centre,  SA
Massive transfusion ,[object Object],[object Object],[object Object]
Who needs massive transfusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Aspects of massive transfusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Aims of the study ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Results ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Massive Transfusion  - Demographics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Injury Severity Score (ISS)   ISS (median) Overall   38 (27-48) Survivors  29 (22-41) Non-survivors  49 (41-57 )
Injury regions 80% of the patients had multiple injuries 08  (10%) Injury to extremities 09  (11%) Facial injuries 47  (59%) Limbs  38  (48%) Injuries to abdomen and pelvis 51  (64%) Chest injuries 42  (53%) Head or neck injuries Patients (%) Different regions
Blood products used  Units 24hrs Median,IQR Units 6hrs Median,IQR 1603 18  (12-28) 1221 13 (9-20) Red cells 679 7  (4-11) 431 4  (2-8) FFP 145 2  (1-3) 80 1  (0-2) Platelets 12 0 4 0 Cryo 2.5 (1.8-3.3) 2.8 (2.0-3.8) RC:FFP 11(9-12) 11(9-15) RC:PLT
Blood products used 0.20 21(13-31) 17 (12-23) RC (24hrs) 0.40 8 (5-13) 6 (4-10) FFP (24hrs) 0.41 2(1-3) 1 (1-3) PLTS (24hrs) 0.66 2.4:1 2.5:1 RC:FFP (24hrs) 0.85 11:1 10.5:1 RC:PLT (24hrs) 26 54 Patients 0.01 18(11-26) 12 (9-17) RC (6hrs) 0.03 7(4-9) 4 (2-8) FFP (6hrs) 0.02 1(0.8-2) 2 (0-1) PLTS (6hrs) 0.60 2.6:1 2.8:1 RC:FFP (6hrs) 0.78 11.4:1 11:1 RC:PLT (6hrs) p-value Non-survivors Survivors
Where are they transfused? 21% of the total units transfused –uncrossmatched O negative or group specific units ICU OT Resuscitation Retrieval Location 57 ( 71%) 60 (75%) 56 (70%) 24 (30%) Patients
Can we predict who needs MT? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Risk factors for the need of massive transfusion ,[object Object],[object Object],[object Object],[object Object],[object Object]
Outcomes ,[object Object],[object Object],[object Object],[object Object],[object Object]
Approaches to massive transfusion  ,[object Object],[object Object],[object Object],[object Object]
Massive Transfusion Pack
Schedule for Massive Transfusion Response Pack RC FFP PLT Cryo rFVIIa 1 5 (O Neg) 2-4 (AB) 1 2 5 4 2 2 3 5 4 2 2 *** 4 5 4 2 5 5 4 2 6 5 4 2 2 7 5 4 2 8 5 4 2 9 5 4 2 2 10 5 4 2
Case study ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],5 RC  2 FFP 1 SDP 1 CRYO 5 RC  4 FFP 1 SDP 1 CRYO 5 RC  2 FFP 1 SDP 5 RC  (O Neg) 2 FFP (AB) 1 SDP MTP4 16.23 MTP3 16.10 MTP2 15.15 MTP1 14.24
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object]
Thank you

More Related Content

What's hot

Massive blood transfusion
Massive blood transfusionMassive blood transfusion
Massive blood transfusionsalamon raja
 
A fresh look at cell salvage
A fresh look at cell salvageA fresh look at cell salvage
A fresh look at cell salvageanemo_site
 
Traumatic haemorrhage
Traumatic haemorrhageTraumatic haemorrhage
Traumatic haemorrhagenswhems
 
Blood a conversation about conservation ex ss 1010113
Blood   a conversation about conservation ex ss 1010113Blood   a conversation about conservation ex ss 1010113
Blood a conversation about conservation ex ss 1010113ess_online
 
Damage control resuscitation
Damage control resuscitationDamage control resuscitation
Damage control resuscitationSCGH ED CME
 
Trauma induced coagulopathy
Trauma induced coagulopathyTrauma induced coagulopathy
Trauma induced coagulopathyAbdulgafoor MT
 
Damage Control in Trauma by Brohi
Damage Control in Trauma by BrohiDamage Control in Trauma by Brohi
Damage Control in Trauma by BrohiSMACC Conference
 
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...mcolumbus
 
Perioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and HaemostasisPerioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and HaemostasisAndrew Ferguson
 
Fluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionFluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionAndrew Ferguson
 
Trauma resuscitation
Trauma resuscitationTrauma resuscitation
Trauma resuscitationSCGH ED CME
 
Blood Transfusion: Rethinking who, what and when
Blood Transfusion: Rethinking who, what and whenBlood Transfusion: Rethinking who, what and when
Blood Transfusion: Rethinking who, what and whenSCGH ED CME
 
reduction of blood loss in burn surgery
 reduction of blood loss in burn surgery reduction of blood loss in burn surgery
reduction of blood loss in burn surgerySumer Yadav
 
Physiological triggers for blood transfusion in the icu
Physiological triggers for  blood transfusion in the icuPhysiological triggers for  blood transfusion in the icu
Physiological triggers for blood transfusion in the icuchandra talur
 
Blood Conservation
Blood ConservationBlood Conservation
Blood Conservationpprashant00
 
2014 siset milano - pavesi - role of fresh frozen plasma, fibrinogen and pro...
2014 siset milano -  pavesi - role of fresh frozen plasma, fibrinogen and pro...2014 siset milano -  pavesi - role of fresh frozen plasma, fibrinogen and pro...
2014 siset milano - pavesi - role of fresh frozen plasma, fibrinogen and pro...anemo_site
 
Massive transfusion protocols
Massive transfusion protocolsMassive transfusion protocols
Massive transfusion protocolsDr.Mahmoud Abbas
 
Jehowah's witnesses and blood conservation strategies by Dr.Minnu M. Panditrao
Jehowah's witnesses and blood conservation strategies by Dr.Minnu M. PanditraoJehowah's witnesses and blood conservation strategies by Dr.Minnu M. Panditrao
Jehowah's witnesses and blood conservation strategies by Dr.Minnu M. PanditraoMinnu Panditrao
 
blood transfusions during pregnancy
  blood transfusions  during pregnancy  blood transfusions  during pregnancy
blood transfusions during pregnancymuhammad al hennawy
 
Massive blood transfusion
Massive blood transfusionMassive blood transfusion
Massive blood transfusionAashissh Shah
 

What's hot (20)

Massive blood transfusion
Massive blood transfusionMassive blood transfusion
Massive blood transfusion
 
A fresh look at cell salvage
A fresh look at cell salvageA fresh look at cell salvage
A fresh look at cell salvage
 
Traumatic haemorrhage
Traumatic haemorrhageTraumatic haemorrhage
Traumatic haemorrhage
 
Blood a conversation about conservation ex ss 1010113
Blood   a conversation about conservation ex ss 1010113Blood   a conversation about conservation ex ss 1010113
Blood a conversation about conservation ex ss 1010113
 
Damage control resuscitation
Damage control resuscitationDamage control resuscitation
Damage control resuscitation
 
Trauma induced coagulopathy
Trauma induced coagulopathyTrauma induced coagulopathy
Trauma induced coagulopathy
 
Damage Control in Trauma by Brohi
Damage Control in Trauma by BrohiDamage Control in Trauma by Brohi
Damage Control in Trauma by Brohi
 
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...Bloodless Medicine   Caring Effectively For Patients Who Decline Blood Transf...
Bloodless Medicine Caring Effectively For Patients Who Decline Blood Transf...
 
Perioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and HaemostasisPerioperative Optimisation of Coagulation and Haemostasis
Perioperative Optimisation of Coagulation and Haemostasis
 
Fluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive TransfusionFluid Resuscitation And Massive Transfusion
Fluid Resuscitation And Massive Transfusion
 
Trauma resuscitation
Trauma resuscitationTrauma resuscitation
Trauma resuscitation
 
Blood Transfusion: Rethinking who, what and when
Blood Transfusion: Rethinking who, what and whenBlood Transfusion: Rethinking who, what and when
Blood Transfusion: Rethinking who, what and when
 
reduction of blood loss in burn surgery
 reduction of blood loss in burn surgery reduction of blood loss in burn surgery
reduction of blood loss in burn surgery
 
Physiological triggers for blood transfusion in the icu
Physiological triggers for  blood transfusion in the icuPhysiological triggers for  blood transfusion in the icu
Physiological triggers for blood transfusion in the icu
 
Blood Conservation
Blood ConservationBlood Conservation
Blood Conservation
 
2014 siset milano - pavesi - role of fresh frozen plasma, fibrinogen and pro...
2014 siset milano -  pavesi - role of fresh frozen plasma, fibrinogen and pro...2014 siset milano -  pavesi - role of fresh frozen plasma, fibrinogen and pro...
2014 siset milano - pavesi - role of fresh frozen plasma, fibrinogen and pro...
 
Massive transfusion protocols
Massive transfusion protocolsMassive transfusion protocols
Massive transfusion protocols
 
Jehowah's witnesses and blood conservation strategies by Dr.Minnu M. Panditrao
Jehowah's witnesses and blood conservation strategies by Dr.Minnu M. PanditraoJehowah's witnesses and blood conservation strategies by Dr.Minnu M. Panditrao
Jehowah's witnesses and blood conservation strategies by Dr.Minnu M. Panditrao
 
blood transfusions during pregnancy
  blood transfusions  during pregnancy  blood transfusions  during pregnancy
blood transfusions during pregnancy
 
Massive blood transfusion
Massive blood transfusionMassive blood transfusion
Massive blood transfusion
 

Viewers also liked

Prevention and treatment of trauma induced coagulopathy (tic). an intended pr...
Prevention and treatment of trauma induced coagulopathy (tic). an intended pr...Prevention and treatment of trauma induced coagulopathy (tic). an intended pr...
Prevention and treatment of trauma induced coagulopathy (tic). an intended pr...anemo_site
 
Abhimanyu singh md anaesthesia new
Abhimanyu singh md anaesthesia newAbhimanyu singh md anaesthesia new
Abhimanyu singh md anaesthesia newgosha30
 
Gratuity Application Letter
Gratuity Application LetterGratuity Application Letter
Gratuity Application LetterYour HR World
 
Letter of Appreciation (Jaguar)
Letter of Appreciation (Jaguar)Letter of Appreciation (Jaguar)
Letter of Appreciation (Jaguar)Shobhit Bafna
 
Blood & Blood Products Transfusion
Blood & Blood Products TransfusionBlood & Blood Products Transfusion
Blood & Blood Products Transfusionlimgengyan
 
Safe blood transfusion practices and policy of hospital
Safe blood transfusion practices and policy of hospitalSafe blood transfusion practices and policy of hospital
Safe blood transfusion practices and policy of hospitalLee Oi Wah
 
Blood transfusion services qc
Blood transfusion services qcBlood transfusion services qc
Blood transfusion services qcNc Das
 
Damage control resuscitation
Damage control resuscitationDamage control resuscitation
Damage control resuscitationSCGH ED CME
 
Letter of Appreciation 2013
Letter of Appreciation 2013Letter of Appreciation 2013
Letter of Appreciation 2013shobegomez
 

Viewers also liked (15)

Massive transfusion
Massive transfusionMassive transfusion
Massive transfusion
 
Prevention and treatment of trauma induced coagulopathy (tic). an intended pr...
Prevention and treatment of trauma induced coagulopathy (tic). an intended pr...Prevention and treatment of trauma induced coagulopathy (tic). an intended pr...
Prevention and treatment of trauma induced coagulopathy (tic). an intended pr...
 
Safe Blood Transfusion
Safe Blood TransfusionSafe Blood Transfusion
Safe Blood Transfusion
 
Abhimanyu singh md anaesthesia new
Abhimanyu singh md anaesthesia newAbhimanyu singh md anaesthesia new
Abhimanyu singh md anaesthesia new
 
Gratuity forms
Gratuity formsGratuity forms
Gratuity forms
 
Gratuity Application Letter
Gratuity Application LetterGratuity Application Letter
Gratuity Application Letter
 
Letter of Appreciation (Jaguar)
Letter of Appreciation (Jaguar)Letter of Appreciation (Jaguar)
Letter of Appreciation (Jaguar)
 
Blood & Blood Products Transfusion
Blood & Blood Products TransfusionBlood & Blood Products Transfusion
Blood & Blood Products Transfusion
 
Safe blood transfusion practices and policy of hospital
Safe blood transfusion practices and policy of hospitalSafe blood transfusion practices and policy of hospital
Safe blood transfusion practices and policy of hospital
 
Blood transfusion services qc
Blood transfusion services qcBlood transfusion services qc
Blood transfusion services qc
 
Damage control resuscitation
Damage control resuscitationDamage control resuscitation
Damage control resuscitation
 
Letter of Appreciation 2013
Letter of Appreciation 2013Letter of Appreciation 2013
Letter of Appreciation 2013
 
Massive Blood Transfusion
Massive Blood TransfusionMassive Blood Transfusion
Massive Blood Transfusion
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Surgical Bleeding
Surgical BleedingSurgical Bleeding
Surgical Bleeding
 

Similar to Massive Transfusion Protocols for Severe Trauma Patients

1 ffp octaplas massive transfusion 35 slides
1 ffp octaplas massive transfusion 35 slides1 ffp octaplas massive transfusion 35 slides
1 ffp octaplas massive transfusion 35 slidesHdailHDARIMCroatia
 
Allogeneic Stem cell transplant in CR1 for AML
Allogeneic Stem cell transplant in CR1 for AMLAllogeneic Stem cell transplant in CR1 for AML
Allogeneic Stem cell transplant in CR1 for AMLspa718
 
Transcatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa forTranscatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa forHans Garcia
 
Septic cmp poster
Septic cmp poster Septic cmp poster
Septic cmp poster jhammes
 
Resucitación Hemostática
Resucitación HemostáticaResucitación Hemostática
Resucitación Hemostáticanfpineda
 
Vedantham_2008-12-12.ppt
Vedantham_2008-12-12.pptVedantham_2008-12-12.ppt
Vedantham_2008-12-12.pptWilliam823183
 
Medullary carcinoma of thyroid genene m. bekele, md, face
Medullary carcinoma of thyroid   genene m. bekele, md, faceMedullary carcinoma of thyroid   genene m. bekele, md, face
Medullary carcinoma of thyroid genene m. bekele, md, faceGofasefer
 
Contraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplantContraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplantDr. Rohit Saini
 
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal AllocationJose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocationincucai_isodp
 
V_Hematology_Forum_Mikhailova_NB_02
V_Hematology_Forum_Mikhailova_NB_02V_Hematology_Forum_Mikhailova_NB_02
V_Hematology_Forum_Mikhailova_NB_02EAFO1
 
Eli Silber - Stem cells
Eli Silber - Stem cellsEli Silber - Stem cells
Eli Silber - Stem cellsMS Trust
 
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 DuffusD1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 DuffusDSHS
 
Ultrasound assisted thrombolysis for vte turkish experience
Ultrasound assisted thrombolysis for vte turkish experienceUltrasound assisted thrombolysis for vte turkish experience
Ultrasound assisted thrombolysis for vte turkish experienceuvcd
 
Rabade_Nikhil_V_Hematology_Forum
Rabade_Nikhil_V_Hematology_ForumRabade_Nikhil_V_Hematology_Forum
Rabade_Nikhil_V_Hematology_ForumEAFO1
 
FACTORS AFFECTING INITIAL CYCLOSPORINE A LEVEL AND ITS CORRELATION WITH CLINI...
FACTORS AFFECTING INITIAL CYCLOSPORINE A LEVEL AND ITS CORRELATION WITH CLINI...FACTORS AFFECTING INITIAL CYCLOSPORINE A LEVEL AND ITS CORRELATION WITH CLINI...
FACTORS AFFECTING INITIAL CYCLOSPORINE A LEVEL AND ITS CORRELATION WITH CLINI...Alok Gupta
 
Hematopoietic Stem Cell Transplantation: High Risk Diffuse Large Cell Lymphoma:
Hematopoietic Stem Cell Transplantation: High Risk Diffuse Large Cell Lymphoma:Hematopoietic Stem Cell Transplantation: High Risk Diffuse Large Cell Lymphoma:
Hematopoietic Stem Cell Transplantation: High Risk Diffuse Large Cell Lymphoma:spa718
 
Fujitani - Vasc Recon in Conjunc Panc Cancer Resec - VNVDA 2023
 Fujitani - Vasc Recon in Conjunc Panc Cancer Resec - VNVDA 2023 Fujitani - Vasc Recon in Conjunc Panc Cancer Resec - VNVDA 2023
Fujitani - Vasc Recon in Conjunc Panc Cancer Resec - VNVDA 2023ssuser787e5c1
 

Similar to Massive Transfusion Protocols for Severe Trauma Patients (20)

1 ffp octaplas massive transfusion 35 slides
1 ffp octaplas massive transfusion 35 slides1 ffp octaplas massive transfusion 35 slides
1 ffp octaplas massive transfusion 35 slides
 
Factors determining outcomes in grown up patients operated
Factors determining outcomes in grown up patients operatedFactors determining outcomes in grown up patients operated
Factors determining outcomes in grown up patients operated
 
Agonistes du récepteur de la thrombopoïétine dans les SMD et AA
Agonistes du récepteur de la thrombopoïétine dans les SMD et AAAgonistes du récepteur de la thrombopoïétine dans les SMD et AA
Agonistes du récepteur de la thrombopoïétine dans les SMD et AA
 
Allogeneic Stem cell transplant in CR1 for AML
Allogeneic Stem cell transplant in CR1 for AMLAllogeneic Stem cell transplant in CR1 for AML
Allogeneic Stem cell transplant in CR1 for AML
 
Transcatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa forTranscatheter intraarterial infusion of rt pa for
Transcatheter intraarterial infusion of rt pa for
 
Septic cmp poster
Septic cmp poster Septic cmp poster
Septic cmp poster
 
Resucitación Hemostática
Resucitación HemostáticaResucitación Hemostática
Resucitación Hemostática
 
Vedantham_2008-12-12.ppt
Vedantham_2008-12-12.pptVedantham_2008-12-12.ppt
Vedantham_2008-12-12.ppt
 
Medullary carcinoma of thyroid genene m. bekele, md, face
Medullary carcinoma of thyroid   genene m. bekele, md, faceMedullary carcinoma of thyroid   genene m. bekele, md, face
Medullary carcinoma of thyroid genene m. bekele, md, face
 
Contraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplantContraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplant
 
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal AllocationJose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
Jose Maria Morales - Spain - Tuesday 29 - HLA for Renal Allocation
 
V_Hematology_Forum_Mikhailova_NB_02
V_Hematology_Forum_Mikhailova_NB_02V_Hematology_Forum_Mikhailova_NB_02
V_Hematology_Forum_Mikhailova_NB_02
 
Eli Silber - Stem cells
Eli Silber - Stem cellsEli Silber - Stem cells
Eli Silber - Stem cells
 
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 DuffusD1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
D1 Highly Active Antiretroviral Treatment (HAART) DHHS Guidelines 2009 Duffus
 
Ultrasound assisted thrombolysis for vte turkish experience
Ultrasound assisted thrombolysis for vte turkish experienceUltrasound assisted thrombolysis for vte turkish experience
Ultrasound assisted thrombolysis for vte turkish experience
 
Rabade_Nikhil_V_Hematology_Forum
Rabade_Nikhil_V_Hematology_ForumRabade_Nikhil_V_Hematology_Forum
Rabade_Nikhil_V_Hematology_Forum
 
PCI & AimRadial 2018 | A Trans-Radial Approach of Cardiac Catheterization f...
PCI & AimRadial 2018 | A Trans-Radial Approach of Cardiac Catheterization f...PCI & AimRadial 2018 | A Trans-Radial Approach of Cardiac Catheterization f...
PCI & AimRadial 2018 | A Trans-Radial Approach of Cardiac Catheterization f...
 
FACTORS AFFECTING INITIAL CYCLOSPORINE A LEVEL AND ITS CORRELATION WITH CLINI...
FACTORS AFFECTING INITIAL CYCLOSPORINE A LEVEL AND ITS CORRELATION WITH CLINI...FACTORS AFFECTING INITIAL CYCLOSPORINE A LEVEL AND ITS CORRELATION WITH CLINI...
FACTORS AFFECTING INITIAL CYCLOSPORINE A LEVEL AND ITS CORRELATION WITH CLINI...
 
Hematopoietic Stem Cell Transplantation: High Risk Diffuse Large Cell Lymphoma:
Hematopoietic Stem Cell Transplantation: High Risk Diffuse Large Cell Lymphoma:Hematopoietic Stem Cell Transplantation: High Risk Diffuse Large Cell Lymphoma:
Hematopoietic Stem Cell Transplantation: High Risk Diffuse Large Cell Lymphoma:
 
Fujitani - Vasc Recon in Conjunc Panc Cancer Resec - VNVDA 2023
 Fujitani - Vasc Recon in Conjunc Panc Cancer Resec - VNVDA 2023 Fujitani - Vasc Recon in Conjunc Panc Cancer Resec - VNVDA 2023
Fujitani - Vasc Recon in Conjunc Panc Cancer Resec - VNVDA 2023
 

Massive Transfusion Protocols for Severe Trauma Patients

  • 1. Massive transfusion in trauma R.Sinha, D.Roxby, R.Seshadri Flinders Medical Centre, SA
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. Injury Severity Score (ISS) ISS (median) Overall 38 (27-48) Survivors 29 (22-41) Non-survivors 49 (41-57 )
  • 9. Injury regions 80% of the patients had multiple injuries 08 (10%) Injury to extremities 09 (11%) Facial injuries 47 (59%) Limbs 38 (48%) Injuries to abdomen and pelvis 51 (64%) Chest injuries 42 (53%) Head or neck injuries Patients (%) Different regions
  • 10. Blood products used Units 24hrs Median,IQR Units 6hrs Median,IQR 1603 18 (12-28) 1221 13 (9-20) Red cells 679 7 (4-11) 431 4 (2-8) FFP 145 2 (1-3) 80 1 (0-2) Platelets 12 0 4 0 Cryo 2.5 (1.8-3.3) 2.8 (2.0-3.8) RC:FFP 11(9-12) 11(9-15) RC:PLT
  • 11. Blood products used 0.20 21(13-31) 17 (12-23) RC (24hrs) 0.40 8 (5-13) 6 (4-10) FFP (24hrs) 0.41 2(1-3) 1 (1-3) PLTS (24hrs) 0.66 2.4:1 2.5:1 RC:FFP (24hrs) 0.85 11:1 10.5:1 RC:PLT (24hrs) 26 54 Patients 0.01 18(11-26) 12 (9-17) RC (6hrs) 0.03 7(4-9) 4 (2-8) FFP (6hrs) 0.02 1(0.8-2) 2 (0-1) PLTS (6hrs) 0.60 2.6:1 2.8:1 RC:FFP (6hrs) 0.78 11.4:1 11:1 RC:PLT (6hrs) p-value Non-survivors Survivors
  • 12. Where are they transfused? 21% of the total units transfused –uncrossmatched O negative or group specific units ICU OT Resuscitation Retrieval Location 57 ( 71%) 60 (75%) 56 (70%) 24 (30%) Patients
  • 13.
  • 14.
  • 15.
  • 16.
  • 18. Schedule for Massive Transfusion Response Pack RC FFP PLT Cryo rFVIIa 1 5 (O Neg) 2-4 (AB) 1 2 5 4 2 2 3 5 4 2 2 *** 4 5 4 2 5 5 4 2 6 5 4 2 2 7 5 4 2 8 5 4 2 9 5 4 2 2 10 5 4 2
  • 19.
  • 20.